School of Food and Biological Engineering, Hefei University of Technology, Hefei, 230009, People's Republic of China.
School of Pharmacy, Anhui Medical University, Hefei, 230032, People's Republic of China.
J Ethnopharmacol. 2024 Jan 30;319(Pt 1):117196. doi: 10.1016/j.jep.2023.117196. Epub 2023 Sep 15.
Parkinson's disease (PD) is the second neurodegenerative disease that lacks effective treatments. Buddlejasaponin IVb (BJP-IVb) is the main bioactive component of herbs in genus Clinopodium which display antioxidative, anti-inflammatory and neuroprotective activities. However, the role of BJP-IVb in PD still remains unknown.
This study aimed to evaluate the effect of BJP-IVb on dopaminergic neurodegeneration in PD and clarified the underlying mechanisms from the aspect of iron overload-mediated ferroptosis.
One-methyl-4-phenylpyridinium (MPP) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD models were established in this study. Behavioral tests, cell cytotoxicity assay, tyrosine hydroxylase (TH) and Nissl staining were performed to evaluate the antiparkinsonian effect of BJP-IVb. Cellular ultrastructure, iron content and lipid peroxidation were detected to evaluate iron overload-mediated dopaminergic neuron ferroptosis. Iron regulatory protein 2 (IRP2) and iron transport-related proteins were detected by immunofluorescence and Western blot to evaluated iron transport. Finally, plasmid vector-mediated IRP2 overexpression were performed to further clarify the molecular mechanism.
BJP-IVb alleviated MPP-induced neurotoxicity in vitro and improved MPTP-induced dopaminergic neuron loss and motor dysfunctions of PD mice, confirming an effect of BJP-IVb against dopaminergic neurodegeneration of PD. Further results revealed that BJP-IVb protected against PD by suppressing iron overload-mediated dopaminergic neuron ferroptosis, as evidenced by the attenuated lipid peroxidation, decreased iron content and changes in cellular ultrastructure. Finally, the decreased iron regulatory protein (IRP2) was confirmed to be responsible for BJP-IVb-mediated ferroptosis suppression by modulating iron transport-related proteins and alleviating iron overload.
BJP-IVb suppressed iron overload-mediated dopaminergic neuron ferroptosis and improved motor dysfunctions in PD, which was achieved by inhibiting IRP2-mediated iron overload. This study provided a potential drug candidate for the treatment of PD.
帕金森病(PD)是第二种缺乏有效治疗方法的神经退行性疾病。川续断皂苷 IVb(BJP-IVb)是唇形科中多种草药的主要生物活性成分,具有抗氧化、抗炎和神经保护作用。然而,BJP-IVb 在 PD 中的作用尚不清楚。
本研究旨在评估 BJP-IVb 对 PD 中多巴胺能神经退行性变的影响,并从铁过载介导的铁死亡角度阐明其潜在机制。
本研究建立了 1-甲基-4-苯基吡啶(MPP)和 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的 PD 模型。通过行为测试、细胞毒性测定、酪氨酸羟化酶(TH)和尼氏染色来评估 BJP-IVb 的抗帕金森作用。通过检测细胞超微结构、铁含量和脂质过氧化来评估铁过载介导的多巴胺能神经元铁死亡。通过免疫荧光和 Western blot 检测铁调节蛋白 2(IRP2)和铁转运相关蛋白,评估铁转运。最后,通过质粒载体介导的 IRP2 过表达进一步阐明分子机制。
BJP-IVb 减轻了 MPP 诱导的体外神经毒性,并改善了 MPTP 诱导的 PD 小鼠多巴胺能神经元丢失和运动功能障碍,证实了 BJP-IVb 对 PD 中多巴胺能神经退行性变的作用。进一步的结果表明,BJP-IVb 通过抑制铁过载介导的多巴胺能神经元铁死亡来保护 PD,这表现在脂质过氧化、铁含量降低和细胞超微结构改变的减轻。最后,通过调节铁转运相关蛋白和减轻铁过载,证实了减少的铁调节蛋白(IRP2)是 BJP-IVb 介导的铁死亡抑制的原因。
BJP-IVb 通过抑制 IRP2 介导的铁过载,抑制铁过载介导的多巴胺能神经元铁死亡,改善 PD 运动功能障碍,为 PD 的治疗提供了潜在的药物候选物。